Articles Archives
Articles
05/26/2026
Dominic Clarke on Reducing Variability Before it Becomes a Problem
As cell therapy programs advance, the pressure on supply chains doesn’t usually come from a single breaking point. It builds gradually, often in ways that aren’t immediately visible during early development. In a recent episode of Beyond Biotech, the podcast from Labiotech, Dominic Clarke, Vice President of IntegriCell® Technical Operations at Cryoport Systems, shares what that progression looks like.
Articles
05/26/2026
Cryoport Systems in Labiotech on Where CGT Supply Chains Start to Break
As more cell and gene therapy programs push toward later-stage trials and commercialization, a familiar set of pressures is starting to surface. What once felt manageable at smaller scale begins to take more effort to hold together as volumes pick up. A recent article in Labiotech, developed in collaboration with Cryoport Systems, looks closely at where that strain comes from and how it often traces back to decisions made much earlier in development.
Articles
10/29/2025
Cryoport Systems Wins CPHI Pharma Award for Supply Chain Excellence
We are proud to announce that Cryoport Systems has been awarded the prestigious Supply Chain Excellence Award at the 2025 CPHI Pharma Awards, a recognition that celebrates innovation, impact, and leadership in pharmaceutical supply chain management. This honor reflects our unwavering commitment to transforming the way life-saving therapies are managed and delivered to patients across the globe.
Articles
07/29/2025
A Glimpse Inside the Future of ATMP Supply Chains: Alison Pritchard on the Beyond Biotech Podcast
In an industry where innovation moves fast but patient access often lags behind, how can we build supply chains that are not only compliant and efficient, but also flexible and ready to scale? That’s the question Alison Pritchard, Vice President of Business Development for Cryoport Systems, tackles in her recent interview with Beyond Biotech, the podcast from Labiotech.eu. Alison explores the state of the advanced therapy medicinal products (ATMP) market in 2025 and what it will take to meet the rising expectations of therapeutic developers, regulators, and – most importantly – patients.
Articles
05/19/2025
Addressing the EMEA Cold Chain Challenge for Cell and Gene Therapies: Cryoport Systems Featured in Labiotech.eu
In a recent Labiotech.eu article, Florent Belon, Managing Director for Cryoport Systems in France, discusses how regulatory diversity, infrastructure gaps, and extreme climate variation across EMEA intensify the need for customized, compliant cold chain solutions.
Articles
05/01/2025
New Article with Contract Pharma: Minimizing Capital Expenditures through Supply Chain Integration
Cryoport Systems has been featured in a new Contract Pharma article, “Minimizing Capital Expenditures through Supply Chain Integration.” This article explores how an integrated supply chain partner like Cryoport Systems helps organizations reduce risk, preserve capital, and gain the flexibility to scale without the burden of building it all themselves.
Articles
04/22/2025
Cryoport Systems Featured in Contract Pharma: The Power of an Integrated Supply Chain
Contract Pharma recently featured Cryoport Systems in a new Q&A article spotlighting our integrated, end-to-end supply chain platform for cell and gene therapies. The piece highlights insights from Matthew Frazzetta, Vice President of Global Accounts, BioServices at Cryoport Systems, and explores how we are supporting the growing needs of life sciences companies around the world.
Articles
01/23/2025